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SETTING STANDARDS FOR THE ASSESSMENT OF OPERATIVE COMPETENCE
Introduction—Aim of Study:
We have previously shown that the operative competence of trainees can be objectively assessed using video
recording and structured checklists. These are useful for feedback (formative assessment). However, for
examination purposes (summative assessment) a standard setting exercise is required.
Materials/Methods:
Videos of a saphenofemoral disconnection by an experienced trainee and a novice were scored by 14 consultant
vascular surgeons and 14 vascular trainees. The observers were also asked to judge whether the surgeon was
competent, borderline or not competent. The observers were blinded as to the experience of the surgeon. The
‘contrasting groups’ method was used to compare the cutpoint between the scores.
Results:
There was complete separation between the scores for the expert (median 16, range 13–18) and the novice
(median 6.5, range 2–12), Chi-square pZ0.0001. This separation was confirmed by the judgements for competent
(14–18), borderline (15–7), and not competent (8–2), pZ0.0001. Trainees scored both the experienced trainee and
novice more harshly than the consultants, although this difference was not significant
Conclusions:
Video recordings of operations can be used for summative assessment. Such recordings could form part of a
trainee’s portfolio.Pandey VA, Black SA, Lazaris AM, Wolfe JHN
On behalf of the European Vascular Workshop, Pontresina
DO WORKSHOPS IMPROVE THE TECHNICAL SKILL OF VASCULAR SURGICAL TRAINEES?
Introduction—Aim of Study:
Adjuncts to conventional surgical training are needed in order to address the reduction in working hours
(EuropeanWorking Time Directive). The purpose of this study was to objectively assess the efficacy of workshop
training on simulators.
Materials/Methods:
15 Consecutive participants of the European Vascular Workshop in 2003 and 2004 were recruited to this study.
Each participant performed a proximal aortic anastomosis on a commercially available aortic aneurysm
simulator. They were given intensive training on sophisticated models and re-assessed. Pre- and post-course
procedures were videotaped and independently reviewed by three assessors (the tapes were blinded and in
random order). The operative end product was similarly assessed. Four validated measures of technical skill
were used:(1)EJVEGeneric skill (OSATS)
(2) Procedural skill (ICEPS)
(3) Five different factors were assessed in the operative end product.
(4) Procedure time was recorded.S Extra Vol 8, Month 2004
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Results:
The video assessment scores for aneurysm repair increased significantly following completion of the course (pZ
0.006 for generic skill and pZ0.004 for procedural skill). End product assessment scores increased significantly
post-course (pZ0.001) and participants performed aneurysm repair faster following the course (pZ0.047). Inter-
observer reliability was high for the two surgical rating scales pre- and post-course (Cronbach’s alphaZ0.95–
0.98). There was also a high reliability coefficient for the aortic inlay end product rating scale (alphaZ0.90 and












Pre Course 10.3–36.3 (17.3) 10–37 (14.7) 5–13 (7.7) 13.56–37.41 (23.26)
Post Course 12–33 (26) 13.3–33.3 (25) 7–19 (14) 12.09–26.46 (16.28)
p value 0.006 0.004 0.001 0.047EJVESConclusions:
This study objectively demonstrates the efficacy of intensive workshop training. Participants perform better,
faster, and with an improved end product following the course. Such adjuncts to training play an important part
in a focused integrated programme that addresses the European Working Time Directive.1
Schouten O, Hoedt MTC, Hop WCJ, Wittens CHA, van Urk H
Department of Vascular Surgery, Erasmus MC Rotterdam, The Netherlands
END TO END VERSUS END TO SIDE DISTAL ANASTOMOSES IN FEMOROPOPLITEAL BYPASSES:
RESULTS OF A PROSPECTIVE, RANDOMIZED TRIAL
Introduction—Aim of Study:
Experimental in vitro studies show a biorheological advantage of end-to-end (ETE) over end-to-side (ETS)
anastomoses for arterial reconstructions. In a retrospective study of 204 patients, we found a trend towards
better patency in ETE femoropopliteal bypasses without a higher risk for amputation after failure of the bypass.
The objective of this trial was to prospectively evaluate the effect of the two different techniques for distal
anastomoses in femoropopliteal bypasses on patency and limb salvage.
Materials/Methods:
This prospective randomized trial involved patients planned for venous or prosthetic above knee (AK) or below
knee (BK) femoro-popliteal bypass for peripheral arterial disease. Randomization to either ETE or ETS distal
anastomosis was done per center, and patients were stratified into four categories: venous and prosthetic AK
bypass, and venous and prosthetic BK bypass. Follow-up was done at 3 months, 6 months and every 6 months
thereafter until 36 months postoperatively. At each follow-up contact, patient history, physical examination and
ankle-brachial pressure index were assessed. Preferably, also a duplex scan was performed. Power calculations
showed that two groups of 160 patients each were needed to demonstrate a difference in patency of 15% (bZ
0.10, 2-sided aZ0.05). Patency rates were calculated on an intention-to-treat basis and the Kaplan–Meier method
was used to compare patency rates.
Results:
In 14 centers 274 patients underwent a total of 328 femoropopliteal bypass operations. Due to anatomical
considerations at the time of surgery, 18 procedures (5.5%) were excluded from further analysis because no
femoropopliteal bypass but a femorotibial or no bypass at all was constructed after randomization. PatientExtra Vol 8, Month 2004
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equally distributed between both groups. Of the 150 ETE distal anastomoses, 2 were AK/vein, 81 were
AK/PTFE, 39 were BK/vein and 28 were BK/PTFE. Of 160 bypasses with an ETS distal anastomosis, 4 were
AK/vein, 89 AK/PTFE, 43 BK/vein and 24 BK/PTFE. Median follow-up was 26 months. Major amputation
(below-knee level or higher) during the in-hospital period was necessary in 11 patients: 7 in the ETE group and 4
in the ETS group (pZ0.29). During follow-up 94 (52 ETS and 42 ETE) bypasses occluded. Occlusion of the bypass
led to major amputation in 13 ETE bypasses and in 5 ETS anastomosed bypasses (pZ0.04). Overall primary
patency was 75 vs 74%, 65 vs 66% and 63 vs 55% for ETE vs ETS after 1, 2 and 3 years respectively (pZ0.34).
Conclusions:
ETE distal anastomosis in femoropopliteal bypasses does not improve patency compared to ETS anastomosis.
Major amputations after failure of the bypass are required more frequently in the distal ETE anastomosed
bypasses.2
Kakkos SK, Geroulakos G, Nicolaides AN
Vascular Unit, Ealing Hospital and Department of Vascular Surgery Imperial College,
London, UK
IMPROVEMENT OF THE WALKING ABILITY IN INTERMITTENT CLAUDICATION WITH SUPERVISED
EXERCISE AND PNEUMATIC FOOT AND CALF COMPRESSION: RESULTS AT SIX MONTHS OF A
RANDOMIZED CONTROLLED TRIAL
Introduction—Aim of Study:
The purpose of this prospective randomized trial is to compare the effect of unsupervised exercise, supervised
exercise and intermittent pneumatic foot and calf compression (IPC) on the claudication distance and lower limb
arterial hemodynamics of patients with intermittent claudication as a result of superficial femoral artery
occlusion.
Materials/Methods:
Thirty-four eligible patients with stable intermittent claudication and absolute claudication distance (ACD)
300 m, selected out of 151 patients screened, were randomized to IPC (ArtAssistw device, model AA-1000, nZ13,
for 3 h/d), supervised exercise (nZ12, three hourly sessions/week on a treadmill in the physiotherapy
department) or unsupervised exercise (nZ9), with stratification for age and walking distance. All patients were
on antiplatelet agents and were asked to exercise daily by walking. In each patient, initial claudication distance
(ICD), ACD, resting ankle brachial pressure index (ABPI), resting and reactive hyperemic calf arterial inflow (15
serial measurements, 15 seconds apart, following 5 minutes of thigh occlusion) were measured before, and six
weeks and six months after randomization, using venous occlusion air plethysmography (APG). Reactive
hyperemic calf arterial inflow was normalized for resting flow, while the hyperemic index (ratio of the area
under the hyperemic curve/peak flow) was also calculated. All results are shown as median and (interquartile
range).
Results:
Compared with unsupervised exercise, both IPC and supervised exercise, increased ICD and ACD, up to 2.6
times (Table). IPC increased arterial inflow (p!0.05 at 6 weeks) and ABPI, and decreased the reactive hyperemic
flow ratio at 15 seconds (at week 6, pZ0.009) and 30 seconds (at week 6, pZ0.01 and month 6, pZ0.028).
Supervised exercise decreased arterial inflow and increased ABPI (p!0.05 at 6 months). Unsupervised exercise
had no effect on arterial inflow or ABPI.EJVES Extra Vol 8, Month 2004
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ICD (m) Unsupervised exercise 70 (22.5) 80 (45) 77.5 (17.5)
Supervised exercise 60 (26.25) 80 (35)* 70 (45)*
IPC 60 (35) 85 (65)* 90 (85)
ACD (m) Unsupervised exercise 135 (87.5) 130 (130) 130 (62.5)
Supervised exercise 145 (108.75) 235 (142.5)** 220 (282.5)*
IPC 145 (145) 295 (210)** 370 (732.5)*
ABPI Unsupervised exercise 0.60 (0.24) 0.60 (0.20) 0.60 (0.13)
Supervised exercise 0.51 (0.14) 0.56 (0.21) 0.62 (0.15)*
IPC 0.56 (0.16) 0.60 (0.08) 0.62 (0.34)
Resting Unsupervised exercise 1.24 (0.81) 1.24 (1.13) 1.28 (0.94)
Arterial Supervised exercise 1.8 (0.80) 1.32 (1.38) 1.26 (0.64)
Inflow (ml/s) IPC 0.9 (0.59) 1.15 (1.04)* 1.04 (0.39)
Hyperemic Unsupervised exercise 2.05 (1.40) 1.97 (1.59) 2.73 (1.75)
Index Supervised exercise 2.26 (2.94) 2.37 (2.59) 2.67 (2.56)
IPC 3.14 (1.27) 1.93 (3.00) 1.99 (2.38)
Intra-group comparison. *p!0.05; **, p!0.01.EJVESConclusions:
IPC, by augmenting leg perfusion, achieved improvement in walking distance comparable with supervised
exercise. No improvement or perfusion changes were seen in patients randomized to unsupervised exercise.
Long-term results in a larger number of patients will provide valuable information on the optimal treatment
modality of intermittent claudication.3
Bapat G, Butler PEM, Hamilton G, Cowen T, Burnstock G, Baker DM
University Department of Surgery, Royal Free and University College Medical School,
London, U.K.
P2X1 RECEPTOR DISTRIBUTION AND CHANGES IN RESPONSE TO HYPOXIA IN COMBINED HUMAN
SKELETAL MUSCLE MICROVESSELS AND CULTURED SMOOTH MUSCLE CELLS
Introduction—Aim of Study:
The P2X1 receptor, is the principal purinergic receptor subtype expressed on vascular smooth muscle cells. This
receptor mediates vasoconstriction after being activated by ATP released as a co-transmitter with nor-
epinephrine from perivascular nerves. Under patho-physiological conditions where endothelium is damaged,
ATP, ADP and UTP released from the platelets act directly on vascular smooth muscle cells causing
vasoconstriction. For the first time we investigated P2X1 receptor expression in smooth muscle cells of human
calf skeletal muscle microvessels and human aortic smooth muscle cells and changes in receptor expression in
response to hypoxia.
Materials/Methods:
Following local ethical committee approval, ten open calf muscle biopsies were obtained from each of two
groups of patients (nZ20): a non ischaemia group undergoing coronary artery bypass surgery and a chronic
ischemia group undergoing surgery for critical limb ischaemia. Human aortic smooth muscle cell culture lines
were grown according to a standard protocol in 8 chamber slides. In the normal group, cells were incubated in a
humidified atmosphere of 5% CO2 in air. In the hypoxic group, cells were exposed to 1% O2/5% CO2/94% N2 in
a Billups-Rothenburge chamber for 18 hours. Each experiment was repeated three times (nZ3). Cells were
immunostained for P2X1 at semi confluent stage. Distribution and changes in purinergic receptor density were
compared between the three groups following immunohistochemistry, using confocal microscopy and
quantitative image analysis.Extra Vol 8, Month 2004
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Immunofluorescence staining identified purinergic receptors P2X1 on smooth muscle cells of skeletal muscle
microvessels and on cultured smooth muscle cells in both normal and hypoxic groups. Image analysis showed a
significant down-regulation of P2X1 receptors in both hypoxic muscle microvessels (p!0.001) and smooth
muscle cells grown under hypoxic conditions (p!0.0001) (statistical analysis: using two way ANOVA followed
by a multiple comparison post test (Tukey test)).
Conclusions:
This study has shown P2X1 expression on human calf skeletal muscle microvessel smooth muscle and aortic
smooth muscle cells. We have shown for the first time that downregulation of P2X1 receptors occurs in vivo and
in vitro in response to chronic ischaemia and hypoxia. This downregulation may represent a protective
physiological response reducing vasoconstriction and thereby maintaining homeostasis.4
Harkin DW, Blair PH, Hood JM, Barros-D’Sa AAB
Regional Vascular Surgery Unit, Royal Victoria Hospital, Belfast, UK
COMPLEX LIMB VASCULAR INJURIES BENEFIT FROM INTRALUMINAL SHUNTING OF VESSELS
Introduction—Aim of Study:
Complex limb vascular injuries (CLVIs) caused by high-energy penetrating or blunt trauma, characterised by
severe vessel damage, fractures, soft tissue loss and often compounded by injuries elsewhere and hypovolaemia,
are associated with a high incidence of ischaemia-reperfusion injury, compartment syndrome, contracture and
amputation. A policy of early intraluminal shunting of both artery and vein in treating CLVIs caused by
terrorism and road accidents was instituted at this centre in 1979.(1)
Materials/Methods:
Shunting was central to a sequence of operative steps, fasciotomy being performed if necessary. The incidence of
fasciotomy, contracture and amputation in penetrating CLVIs (PCLVIs) during 1969–1978 (pre-shunt) was
compared to that during 1979–2000 (post-shunt) and similarly for blunt CLVIs (BCLVIs). PLCVIs included 34
pre-shunt and 57 post-shunt cases and BCLVIs 38 pre-shunt and 49 post-shunt cases. Comparison and analysis
was by c2 test (Yates’ corrected) and Fischer’s exact test (when appropriate). Corresponding odds ratios (OR)
and 95% confidence interval (CI) values were calculated; variables were statistically significant at p!0.05 level.
Results:
PCLVIs Fasciotomy: pre-shunt 17/30 (56.7%) post-shunt 13/48 (27.1%), OR 3.5, CI 1.3–9.2, pZ0.016; Contracture:
pre-shunt 13/30 (43.3%) post-shunt 8/47 (17.0%), OR 3.7, CI 1.3–10.6, pZ0.018; Amputation: pre-shunt 11/34
(32.4%) post-shunt 5/57 (8.8%), OR 5.0, CI 1.6–16.0, pZ0.009. BCLVIs Fasciotomy: pre-shunt 22/35 (62.9%) post-
shunt 16/44 (36.4%), OR 3.0, CI 1.2–7.4, pZ0.02; Contracture: pre-shunt 19/34 (55.9%) post-shunt 13/45 (28.9%),
OR 3.1, CI 1.2–7.9, pZ0.02; Amputation: pre-shunt 15/38 (39.5%), post-shunt 7/49 (14.3%), OR 3.9, CI 1.4–11.0,
pZ0.012.
Conclusions:
Early restoration of arterial inflow and venous outflow by shunts abbreviates limb ischaemia and IRI, buying
time for meticulous care of both penetrating and blunt CLVIs, significantly reducing the fasciotomy rate and the
incidence of contracture and amputation. This policy also fosters a climate of multidisciplinary cooperation.
(1) Barros-D’Sa, AAB. Annals Roy Coll Surg Eng 1982; 64: 37–44EJVES Extra Vol 8, Month 2004
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Kosugi I, Ohtake H, Kimura K, Nagamine H, Watanabe G,a Shiobara Sb, Nakajima Kc
aThe Department of General and Cardiothoracic Surgery
bThe Department of Blood Transfusion
cThe Department of Nuclear Medicine, Kanazawa University Hospital, Japan
THE EVALUATION FOR THERAPEUTIC ANGIOGENESIS BY THE MUSCULAR BLOOD FLOW SCINTI-
GRAPHY USING TI-201: TRIAL FOR ESTABLISHMENT OF OBJECTIVE INDEX
Introduction—Aim of Study:
Therapeutic angiogenesis for severe limb ischemia might be the most optimal strategy. Various post-therapeutic
evaluations are performed, but examination for overall blood flow of the ischemic limb has not been reported.
We aimed to clarify the effectiveness of post-therapeutic evaluation using muscular blood flow scintigraphy
using Tl-201.
Materials/Methods:
Five limbs of five patients with severe ischemia underwent therapeutic angiogenesis using CD34Ccells in bone
marrow. The causative diseases were arteriosclerosis obliterans in three patients, and thromboangitis obliterans
in two. Preoperative Fontaine classifications were III for one patient and IV for four patients. Visual analog scale
(VAS) for limb pain, ankle brachial pressure index (ABPI), angiography, thermography, skin blood flow, and
muscular blood flow scintigraphy using Tl-201 were examined preoperatively. The scintigraphy was performed
at rest and under prostaglandin E1 endurance, and several indices were calculated. Preoperative VAS was 10
points in all patients. Under general anesthesia, CD34Ccells (3.7G0.6!107) were collected from iliac bone
marrow and injected into the ischemic muscle of lower extremities. Every examination was performed
postoperatively.
Results:
In four patients (Fontaine III, one patient; Fontaine IV, three patients), symptoms disappeared (VAS: 0–2 points)
at three to four days after therapeutic angiogenesis. In one Fontaine IV patient, rest pain continued (VAS: 10
points). There was no significant difference between pre-therapeutic and post-therapeutic findings of
angiography, thermography, and skin blood flow. An equilateral correlation was recognized only in
scintigraphic scores of the curs/thigh ratio at rest and VAS.
Conclusions:
Therapeutic angiogenesis of CD34C cells is effective, and the symptoms in 80% of our patients disappeared. The
count ratio between curs and the thigh at rest was reflected in the VAS. We suggest that muscular blood flow
scintigraphy can be an effective objective evaluation.6
Dr. Salmero´n LM1, Dr. Ramos VE1, Carrero JJ2, Baro´ L2, Lo´pez-Hue´rtas E2, Ros E1
Service of Angiology and Vascular Surgery at S. Cecilio Hospital in Granada, Spain1; Puleva
Biotech. Granada, Spain2
SUPPLEMENTATION WITH N-3 FATTY ACIDS, OLEIC ACID AND FOLIC ACID ENRICHED MILK:
BENEFICIAL EFFECTS ON THE CLINIC AND ON LIPID PROFILE IN FREE-LIVING PERIPHERAL
VASCULAR DISEASE (PVD) PATIENTS.
Introduction—Aim of Study:
To analyse the in vivo effects of n-3 fatty acids, oleic acid and folic acid enriched-milk on plasma lipid profile and
in the clinic in free-living Spanish male patients with PVD.EJVES Extra Vol 8, Month 2004
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Prospective, descriptive, randomised and double blind study, with two groups of patients with claudication for
chronic ischemia of their legs. Omega-3 group(U): nZ30, their diet was supplemented with 500 cc/day of semi-
skimmed milk enriched with n-3 fatty acids oleic acid and folic acid. Control group (C), nZ24, were given 500
cc/day of semi-skimmedmilk. Both groups were homogeneous insofar as risk factors, claudication distance and
lipid profile were concerned. Treatment in both groups: Same dietetic recommendations, an antiplatelet and
pentoxfylline. Patients were followed for 12 months, with controls in base line, 3–6–9–12 months. A dietetic test,
a clinical vascular examination, treadmill, Yao index, plethysmography and blood test with lipid profile were
done in every control. Statistical analysis applied consisted in Repeated Measures ANOVA and independent t
test. A multivariant analysis was also performed.
Results:
U group tripled their claudication distance (pZ0.000). Yao index in the U group went from 0.46 to 0.52 (pZ0.01).
Total cholesterol decreased only in the U group (pZ0.03). Triacylglycerol levels did not change.
Conclusions:1.EJVDiet is fundamental to the control of dyslipidaemia and PVD.
2. Small doses of n-3 fatty acids, oleic acid and folic acid administered in the milk may be useful in the
nutritional management of patients suffering PVD, increasing the claudication distance and Yao index and
reducing the cholesterol levels7
Olofsson P, Lettersta˚hl A, Wahlberg E
Department of Vascular Surgery, Karolinska Hospital, Stockholm, Sweden
THE COST-EFFECTIVENESS OF INTERVENTIONS FOR SEVERE INTERMITTENT CLAUDICATION
Introduction—Aim of Study:
In times of health care funding restrictions the cost effectiveness of invasive treatment for intermittent
claudication (IC) is sometimes questioned. We therefore evaluated the cost for invasive treatment in patients
with IC in relation to quality of life (Qol) and health utility outcome measures
Materials/Methods:
Fifty consecutive patients with IC selected for bypass or PTA were included. The patients completed Qol
instruments and a treadmill test before surgery and 6 months postoperatively. Standard gamble (SG) and time
trade off (TTO) scores were obtained at the same time points. Direct and indirect costs for the procedures were
estimated from the medical records.
Results:
The patients’ preoperative mean ABI was 0.54 (SD 0.22) and their ACD (14% inclination, speed 2.5 km/h) was 51
(35) meters. At follow up the corresponding values were 0.74 (0.22, PZ!0.0001) and 83 (57) meters (pZ0.0005).
Patients experienced a significant reduction in pain score and impact of daily life (p!0.001, WIQ and PZ0.01,
EuroQol-5D). The Qol the last 6 months also increased and derived TTO improved with 0.2 after treatment (p!
0.001 andZ0.003 EuroQol-5D). TTO and SG scores indicated severe impact on health perception and patients
were willing to risk around 30% of their remaining life span to be relieved from their walking problems. The
mean costs for PTA were estimated to 5500 Euro, and for open surgery 8500 Euro in our hospital for 2003.
Conclusions:
IC significantly decrease QoL and influences health perception. The health utility outcome scores are similar or
worse than for patients with osteoarthritis undergoing arthroplasty. In spite of a rather modest increase inES Extra Vol 8, Month 2004
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TTO of 0.2 corresponds to a gain of 12,000 Euro—well over the cost for treatment. Accordingly, at least short
term, interventions for IC appears to be cost effective.8
Wiernicki IA, Gutowski P, Cyrylowski L
Department of Vascular Surgery, Department of Imaging Diagnostic and Interventional
Radiology, Pomeranian Medical University, Szczecin, Poland
PATHOGENESIS OF ABDOMINAL AORTIC ANEURYSM RUPTURE—ASSOCIATION WITH INTRALUM-
INAL THROMBUS MORPHOLOGY, LOCAL ACID-ALKALINE STATUS AND ELASTASE ACTIVITY
Introduction—Aim of Study:
In one of the latest papers, Vorp and co-workers suggest that there is local hypoxia in the region of thicker
intraluminal thrombus (ILT) due to decreased oxygen diffusion from aorta lumen to the abdominal aortic
aneurysm (AAA) wall. Sakalihasan’s observations, showing that gelatinolytic activity in ILT decreases the
further it is located from the blood flow channel (BFC), indicate that there may be a relation between elastolytic
activity in AAAwall and the thickness of thrombus. The aim of this study was to determine ILTmorphology and
experimental verification of association of acid-alkaline status (pH) in AAAwall with thickness of adhesive ILT.
Materials/Methods:
144 patients with AAAwere examined with the application of ultrasound, computed tomography and magnetic
resonance imaging concerning the evaluation of ILT thickness and BFC localization. ILT thickness
measurements were performed in the AAA maximal diameter. In 25 cases, pH intramural measurements of
the adhesive regions of the thickest and thinnest ILT were performed intraoperatively in the AAA maximal
diameter.
Results:
In 67% cases of AAAO49 mm BFC inside ILTwas located near the posterior wall of aneurysm; in AAA of 40–
49 mm—46% and in AAA 30–39 mm—24%. Intramural pH measured in the adhesive region of the thickest and
thinnest ILT was the mean value of 7,22 (7.00–7.43), and 7.63 (7.50–7.78) respectively.
Conclusions:
In the majority of big aneurysm cases the BFC is located near the posterior wall. Intramural pH (7.6), in the
vicinity of the thinnest ILT is favourable for optimal elastase activity in aneurysmal wall. Locally increased pH,
creating optimal conditions for elastase activity, may have a significant role in pathogenesis of abdominal aortic
aneurysm rupture. It is suggested to determine elastase and matrix metalloproteinases activity in AAA wall
from samples collected from pH measurement regions. In enrolment for surgery, ILT morphology should be
considered.9
Korhonen SJ, Pettila¨ V, Kantonen I, Salo JA, Ohinmaa A, Lepa¨ntalo M
Department of Vascular Surgery, Helsinki University Central Hospital, Finland
QUALITY ADJUSTED LIFE YEARS AFTER RUPTURED ABDOMINAL AORTIC ANEURYSM
Introduction—Aim of Study:
Repair for RAAA is expensive and successful only in some 50%. There are doubts of the quality of life thisEJVES Extra Vol 8, Month 2004
ESVS Abstracts—200454procedure is able to produce. Assessment of quality adjusted life years (QALYs) is aimed to combine the
quantity and quality of life (QoL) to give objective figure of success. One QALY represents one year of life with
perfect QoL. Aim of this study was to assess QALYs after RAAA and factors related to QALYs.
Materials/Methods:
Between 1996 and 2000, 176 of 197 patients with RAAA underwent surgery. Survivors were sent the EQ-5D self-
administrated questionnaire to assess the long-term outcome. EQ-5D single index values were calculated for
each survivor and they were combined to age- and sex-adjusted Finnish life-tables to obtain QALY estimates.
Age, gender, date of surgery and/or death, co-morbidities, preoperative factors, preoperative scores (APACHE
II; SOFA; GlasgowAneurysm Score; Hardman index), perioperative and postoperative conditions, and length of
intensive care unit and hospital stay were recorded retrospectively.
Results:
Total hospital mortality and operative mortality were 100 of 197 (50.7%) and 79/176 (44.7%). Of the 97 surviving
patients 83 patients remained left for QoL evaluation. Response rate was 84% (70/83). The mean (range) QALYs
after RAAA were 2.8 (0–23.6) for all and 5.7 (0.1–23.6) for hospital survivors. Young age and low Glasgow
Aneurysm Score were associated with high QALYs. Linear regression and Bayes model revealed that only
Glasgow Aneurysm Score and age were independently (p!0.0001) associated with QALYs. Logistic regression
analysis showed that the same two factors were the only independent predictors of hospital mortality.
Conclusions:
Successful repair for RAAAwas able to bring about considerable benefit as shown by achieving more than mean
of 5 QALYs. Repair of RAAA should not be denied because of high age and high Glasgow Aneurysm Score
despite their predictive value.10
Tshomba Y, Melissano G, Civilini E, Setacci F, Chiesa R
Vascular Surgery Dept. University Vita-Salute San Raffaele; Scientific Institute H. San Raffaele,
Milan, Italy
FATE OF THE VISCERAL AORTIC PATCH AFTER THORACOABDOMINAL AORTIC REPAIR
Introduction—Aim of Study:
Thoracoabdominal aortic aneurysm (TAAA) repair requires visceral vessels revascularization which is usually
performed with a visceral aortic patch (VAP) anastomosed to the aortic graft. This study analyses the fate of VAP
in the patients that underwent TAAA surgery at our Institution.
Materials/Methods:
We reviewed 204 consecutive patients (158 M, 46 F, mean age 66.3G8.1 years) treated for TAAA between 1988
and 2004. In most cases the aetiology of the TAAAwas atherosclerosis. We performed VAP in 182 cases. Among
the 149 survivors at 6 months, we followed 138 cases (mean follow up 7.3 years, range 0.6–16 years). The mean
graft diameter we used was 28.7 mm (range 24–34 mm) from 1988 to 1999 (83 patients), and 21.7 mm (range 16–
24 mm) from 2000 to 2003 (55 patients). In 22.5% of cases we performed a separate bypass to the left renal artery
(LRA).
Results:
We observed 16 (11.6%) VAP dilatations (!5 cm) and 5 (3.6%) VAP aneurysms (O5 cm). The mean time after
operation was 6.3 years. In all cases the TAAAwas atherosclerotic. There were no VAP dilatations/aneurysms in
the group of patients with separate revascularization of LRA. All the VAP aneurysmswere treated electively. In 4
cases the operation was performed with thoracophrenolaparotomy, in 1 case with a bilateral subcostal
laparotomy. In all cases the visceral aorta was re-grafted. Reimplantation of a single undersized VAP wasEJVES Extra Vol 8, Month 2004
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hypotermic perfusion of visceral and renal arteries was used in all the patients. There was 1 perioperative death;
2 patients with preoperative renal failure required dialysis.
Conclusions:
Aneurysm of VAP is not uncommon in the patients operated using larger grafts with a single VAP that includes
the LRA (7.4%, 5/67 cases). Its treatment carries significant mortality and morbidity.11
Visser P, Akkersdijk GJM, Blankensteijn JD
University Medical Center St. Radboud, Nijmegen, The Netherlands; Spaarne Ziekenhuis,
Haarlem, The Netherlands
OPERATIVE MORTALITY OF RUPTURED AAA: A NATIONAL ANALYSIS OF 5593 PATIENTS OVER ATEN
YEAR PERIOD
Introduction—Aim of Study:
The aim of this study was to quantify, in a population-based analysis, in-hospital mortality of ruptured
infrarenal abdominal aortic aneurysm (RAAA) repair in the Netherlands over a 10-year period.
Materials/Methods:
We retrospectively studied the nation-wide in-hospital mortality of infrarenal RAAA repair between 1991 and
2000. Data were obtained from Prismant, The Institute for Health Care Management. This is a national registry
for medical diagnosis and procedures to which all hospitals in The Netherlands report. Variables studied
included age, gender, date of surgery and hospital class (0–399 beds, R400 beds or university hospitals).
Results:
The overall in-hospital mortality of (conventional) RAAA repair in 5593 patients in the 10-year period was 41 per
cent (95 per cent confidence interval: 40–42 per cent). In multivariate analysis age and hospital class were the
most important independent predictors for in-hospital mortality. Gender and date of surgery were not identified
as significant risk factors for in-hospital mortality.
Table 1. Multivariate analysis of 5593 patients with ruptured infrarenal aortic abdominal aneurysm repair over the decade 1991–2000.
Multiple Linear Regression Analysis of 5593 patients, RZ0.277
Variable Parameters Beta T-value P-value
Age Years 0.269 21 !0.0005
Hospital class 1: 0–399 beds 0.047 4 !0.0005
2:O400 beds
3: University Hospital
Gender 1: Male, 2: Female 0.016 1 0.233
Season Spring 0.006 0.382 0.702
Summer K0.028 K1.784 0.075
Fall K0.006 K0.365 0.715
Winter 0.006 0.348 0.719
Year Year of surgery K0.01 K0.759 0.448
(Constant) K12.012 !0.0005EJVESConclusions:
Over a recent decade, population-based in-hospital mortality of conventional RAAA repair remained
unchanged at about 40 per cent. Patient age and type of hospital class were the most important independent
risk factors.Extra Vol 8, Month 2004
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Alsac J-M, Zarins CK, Heikkinen M, Becquemin J-P
Henri-Mondor University Hospital, Creteil, France; Stanford University Hospital, California,
USA
DOES SUPRARENAL FIXATION OF AORTIC ENDOGRAFT IMPAIR RENAL FUNCTION?
Introduction—Aim of Study:
To determine whether suprarenal fixation of endografts used to treat infrarenal AAA impairs renal function.
Materials/Methods:
Retrospective analysis of 277 patients treated from 2000 to 2003 with 3 different endografts at 2 clinical centers.
Five patients on dialysis for preoperative chronic renal failure were excluded. Group A of 135 patients treated
with an infrarenal device (Medtronic AneurX) was compared to group B of 137 patients treated with a
suprarenal device (106 Cook Zenith, and 31 Medtronic Talent). Renal function was evaluated by calculating
preoperative and latest postoperative creatinine clearance (ClCr) using the Cockcroft formula. Patients who
developed a O20% decrease in ClCr were considered to have significantly impaired renal function.
Results:
There were no significant differences in patient age, sex, aneurysm size, preoperative risk factors, or baseline
ClCr (A: 69.3 ml/min, B: 71.7 ml/min, PZ0.4). Follow-up time was the same in both groups: 12.2 months. ClCr
decreased significantly during the follow-up period in both groups (A: 69.3 ml/min to 61.7 ml/min, P!0.01; B:
71.7 ml/min to 64.9 ml/min, P!0.03). Postoperative ClCr (A: 61.7 ml/min, B: 64.9 ml/min, PZ0.3), and rate of
ClCr decrease during the follow-up period (A:K10.9%, B:K9.5%, PZ0.2) were not different between the two
groups. The number of patients with aO20% decrease in ClCr was not different between the two groups (A: nZ
35 (25.9%), B: nZ41 (29.9%), PZ0.46). However, the magnitude of decrease in ClCr in patients with renal
impairment was significantly greater in patients treated with suprarenal fixation endografts (B: K39%)
compared to those treated with infrarenal endografts (A: K31%, PZ0.005). This greater degree of renal
impairment was not due to identifiable differences in preoperative risk factors, age or baseline ClCr. No patients
in these series required dialysis.
Conclusions:
Regardless the type of endograft used, there is a similar mild decrease overtime in ClCr following aortic
endografting. However, among patients who experience significant renal impairment, suprarenal fixation is
associated with a greater magnitude of loss of renal function. Long follow-up of ClCr, along with renal imaging,
should be performed in order to recognize possible late renal dysfunction. Prospective studies comparing
suprarenal versus infrarenal fixation are needed to confirm these results.13
Zarins CK, Crabtree T, Arko FR, Bloch D, Ouriel K, White RA
Stanford University, Divisions of Vascular Surgery and Health Research Policy; Cleveland
Clinic Foundation; Harbor-UCLA Medical Center, USA
ENDOVASCULAR REPAIR OR SURVEILLANCE OF PATIENTS WITH SMALL AAA
Introduction—Aim of Study:
To determine the risk of aneurysm rupture and death in patients with small AAA treated in a prospective trial of
endovascular repair (EVAR) in comparison to a prospective surveillance protocol.EJVES Extra Vol 8, Month 2004
ESVS Abstracts—2004 57Materials/Methods:
Review all clinical trial patients (nZ478) with small (!Z5.5 cm) AAA treated with EVAR in a prospective,
multicenter trial (1997–1999) with follow up through 2003. Comparison of age (60–76years) and size (4.0–5.5 cm)
matched sub-group (MatchEVAR) to the surveillance patient cohort (UK) of the UK Small Aneurysm Trial
(NEJM345:1445,2002).
Results:
MatchEVAR (nZ312) excluded 151 patients for age!60O76years and 15 for AAA diameter !4 cm and was
similar (age 70C4 years, AAA diameter 5.0C0.3 cm) to the 527 UK surveillance patients (age 69C4 years, AAA
diameter 4.6C0.4 cm). There were no significant differences between EVAR and MatchEVAR. Mean follow up
for EVAR was 2.9C1.2 years and for UK 5.8 years. Statistical comparisons were made for rates per 100 patient
years of follow up (100 years) to correct for differences in FU time.
EVAR (nZ478) MatchEVAR (nZ312) UK (nZ527) p value1
Operative mortality (30
day)
1.3% 1.9% 7.2%2 0.001
One year rupture risk 0.4% 0.3% 1%
Total fatal ruptures 0.4% 0.6% 4.6%
Fatal ruptures/100 years 0.1 0.2 0.8 0.001
Total AAA deaths 1.7% 2.2% 11.6%
AAA deaths/100yrs 0.6 0.8 2.0 0.001
Total mortality 19% 18% 48%
Deaths/100yrs 6.6 6.3 8.3 0.02EJVESBased on a comparison of MatchEVAR vs. UK
28 of 389 patients who had surgical repair
Conclusions:
It appears that EVAR may reduce the risk of rupture, AAA related death and overall mortality in patients with
small aneurysms compared to surveillance strategies. Prospective comparative trials are needed to confirm
these results.14
Vainas T, Stassen FRM, Schurink GWH, Tordoir JHM, Welten RJThJ, van den Akker LHJM,
Kurvers HAJM, Bruggeman CA, Kitslaar PJEHM
Maastricht University Hospital, The Netherlands
SECONDARY PREVENTION OFATHEROSCLEROSIS THROUGH CHLAMYDIA PNEUMONIAE ERADICA-
TION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: A RANDOMISED CLINICAL TRIAL
Introduction—Aim of Study:
Sero-epidemiological and animal experimental studies suggest that C. pneumoniae infections play an important
role in the development of atherosclerosis. Clinical trials have shown contradictory results regarding the efficacy
of antibiotics to prevent atherosclerosis-related complications in patients with coronary artery disease. Our aim
was to study the effect of a short course of antibiotics on the incidence of cardiovascular events and peripheral
vascular function in patients with stable peripheral arterial disease (PAD).
Materials/Methods:
509 PAD-patients were recruited, randomised to receive a 3-day course of azithromycin (500 mg daily) or
placebo, and followed during 2 years. Clinical endpoints were death (all cause mortality), coronary (myocardial
infarction, unstable angina, and/or coronary revascularization procedures), cerebral (stroke, TIA, and/or
carotid endarterectomy) and peripheral arterial complications (increased PAD-symptoms with decreased ankle-Extra Vol 8, Month 2004
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decrease of ABI after 6 months.
Results:
509 PAD-patients (160 women) with an atherosclerotic risk factor profile were included. 449 patients (88%) had
intermittent claudication and 60 (12%) had critical limb ischemia. 257 patients were randomised to receive
azithromycin and 252 patients the placebo. A remarkably high number of patients reached a clinical endpoint
during an average 22-month follow up. In total, 163 patients (32%) developed 238 complications (37 deaths, 34
coronary events, 35 cerebral events and 132 peripheral arterial complications). The number of complications (123
in the azithromycin group vs. 115 in the placebo group) and the number of patients that developed
complications (87 (39%) in the azithromycin vs. 76 (31%) in the placebo group) was comparable in both groups.
Life table analysis showed no effect of azithromycin on survival. Neither had azithromycin any effect on
(changes in) ABI.
Conclusions:
A short-term antibiotic course offers no benefits in terms of survival or improved peripheral vascular function in
PAD-patients.15
Setacci C, Setacci F, de Donato G, Pieraccini M, Palasciano G, Cappelli A, Trovato RA,
Benevento D
Department of Vascular and Endovascular Surgery, University of Siena, Italy
IN-STENT RESTENOSIS AFTER CAROTID ANGIOPLASTY AND STENTING: A CHALLENGE FOR THE
VASCULAR SURGEON
Introduction—Aim of Study:
Carotid angioplasty and stenting (CAS) has emerged as a safe and less invasive alternative to carotid
endarterectomy (CEA). Emergence of a position of clinical equipoise on the relatively equivalent value of these
therapeutic alternatives has led to the design and initiation of multiple trials comparing CAS versus CEA for the
treatment of carotid occlusive disease. Despite the refinement of the CAS technique for the endovascular
treatment of carotid artery disease, the issue of in-stent restenosis (ISR) remains of significant concern. Although
the current approach to the treatment of ISR is relatively simple, newer, more aggressive approach are currently
at the investigational level and include intravascular brachytherapy, antiproliferative therapy with drug-coated
stents used in other vascular beds, biodegradable stents and cutting balloon technique.
Materials/Methods:
Interrogating our Department’s computerized data base we have identified 418 patients (334 men, mean age 63
years, range 46–86, median 65 years) treated with CAS, wich represented 29.5% of the 1416 patients scheduled
for carotid surgery, between December 2000 and March 2004. 372 (89%) patients had at least one ultrasound
evaluation done six months after the procedure (range 6–34). A large number of the patients (72.8%) were
symptomatic; 11 patients (0.2%) had bilateral lesions. Stenting was performed for de novo stenoses in 230
(55.1%) and for postendarterectomy recurrent stenosis in 188 carotid axes (44.9%). We performed 411 elective
(98.4%) and 7 emergent procedures (1.6%).
Results:
Overall perioperative complications included 4 (0.9%) minor strokes, and 2 (0.4%) major strokes (1 intracranial
haemorrhage and 1 haemispheric stroke); the latter 2 patients died at 5 and 12 days after the operation. No other
deaths occurred. One of the minor stroke patients underwent successful urgent surgical treatment for in-stent
thrombosis. 14 patients, for a total of 15 carotid axes (3.6%), in 1 case the restenosis was bilateral, had ISR. Double
(tandem) ISR was found in 2 cases. The segments affected by restenosis were 3 proximal ends (common carotidEJVES Extra Vol 8, Month 2004
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80%), 7 patients were symptomatic and 6 asymptomatic; in the 2 cases of moderate ISR, reintervention was
recommended because of the presence of accompanying contra-lateral occlusion. All ISR were treated: 6 with
balloon dilatation (one bilateral) and the remaining 9 with secondary stenting. The results of multivariate
analysis demonstrated the multifactorial origin of the condition: previous surgical carotid restenosis (OR 5.8),
postoperative fever (OR 3.9) and the need of carotid predilatation with concomitant malignancy or autoimmune
disease (OR 3.2) are key predictors for development of ISR. Interestingly, non significant risk factors were
diabetes, patient age and the length, diameter, material or type of the stent.
Conclusions:
The present study supports the multifactorial origin of ISR and indicates some peculiar risk factors not
previously described in the literature. Although CAS is strongly recommended for postendarterectomy
restenosis, a greater risk of ISR may reduce the benefits of this procedure. In candidates to CAS presenting
individual risk factors, closer clinical and imaging follow-up are warranted.16
Fairhead JF, Rothwell PM
Stroke Prevention Research Unit, Department of Clinical Neurology, Oxford University, UK
A POPULATION-BASED STUDY OF THE TIMING OF CAROTID IMAGING AND ENDARTERECTOMY
Introduction—Aim of Study:
Current UK guidelines are that carotid endarterectomy should be performed within 6 months of a TIA of stroke.
However, recent analysis of trial data has shown that benefit from surgery is more heavily time-dependant. For
70–99% stenosis benefit is greatest if surgery is performed within 2 weeks and falls rapidly with time, with only
modest benefit after 12 weeks. Patients with 50–69% stenosis only gain significant benefit if operated on within 2
weeks of an event. The gap between these findings and current practice is unknown.
Materials/Methods:
We performed a population-based audit of the timings of referral for carotid imaging, imaging and
endarterectomy in the whole of Oxfordshire (populationZ680,772) by clinical indication. Data were collected
on all referrals for carotid ultrasound, MRA, CTA or angiography for one year (2002/2003) in Oxfordshire using
computerised and written attendance records from all imaging centres in Oxford and surrounding regions and
these were cross-referenced with operation records.
Results:
Imaging was done for 855 ischaemic cerebral or retinal events, of which 821 (96%) had reliable data on timings.
Forty-nine patients subsequently had an endarterectomy. Median times from event to referral, imaging and
endarterectomy were 9, 33 and 100 days respectively. Only 6% of endarterectomies were performed within 2
weeks and 35% within 12 weeks. Patients initially investigated as inpatients were imaged more rapidly (median
10 vs 44 days, p!0.0005).
Conclusions:
Our data show that whilst the majority of patients with TIA or ischaemic stroke in Oxfordshire are treated within
current guidelines, the timing of investigation is too slow to allow maximum benefit from endarterectomy.EJVES Extra Vol 8, Month 2004
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Regional Unit of Vascular and Endovascular Surgery, Belfast City Hospital, Belfast, UK
THE EFFECTOF PRAVASTATINON INTIMAMEDIATHICKNESS OF THE CAROTID ARTERY IN PATIENTS
WITH NORMAL CHOLESTEROL
Introduction—Aim of Study:
Carotid intima media thickness (IMT) is a good indicator of the severity of atherosclerotic disease. Statins have
been found to reduce carotid IMT in patients with hypercholesterolaemia. The aim of this study was to
investigate if Pravastatin is effective in reducing IMT in normocholesterolaemic patients with carotid artery
disease.
Materials/Methods:
Patients with carotid artery stenosis and cholesterol levels below 5.5 mmol/l, who were not on a statin, were
recruited. Patients were randomised in a blinded fashion to receive 40 mg of Pravastatin or placebo daily. Serum
concentration of cholesterol and IMT of right and left common carotid arteries were measured before
randomisation and at 3 monthly intervals thereafter, for 9 months. IMTwas analysed using an HDI laboratory
research programme to give the mean of a standardised 2 cm of the common carotid artery. Results are
expressed as mean (SEM) and comparison made using the paired t test.
Results:
54 patients (108 carotid arteries) were examined. 28 patients were randomised to active treatment. There was no
difference in demographic details and co-morbid states between the two groups. A significant reduction in
cholesterol concentration and IMTof the common carotid artery was observed in patients prescribed Pravastatin
in comparison to the placebo group (Tables 1 and 2).
Conclusions:
The results demonstrate that Pravastatin may reduce intima media thickness of the common carotid artery in
normocholesterolaemic patients with moderate carotid stenosis. This finding reinforces evidence suggesting
that statins may be beneficial even in patients with relatively low cholesterol concentrations.Table 1. Cholesterol (mmol/l)
Baseline 3 months 6 months 9 months
Pravastatin(nZ28) 5.30G0.15 4.34G0.20* 4.25G0.19* 4.30G0.29*
Placebo(nZ26) 5.37G0.19 4.93G0.25* 5.15G0.25 5.37G0.29
Table 2. Intima media thickness (mm)
Baseline 3 months 6 months 9 months
Pravastatin(nZ56) 0.83G0.04 0.80G0.04* 0.77G0.03* 0.74G0.03*
Placebo(nZ52) 0.76G0.03 0.76G0.03 0.80G0.03 0.78G0.04
* Significant decrease compared to baseline value, p!0.05.18
Daskalopoulou SS1,6; Daskalopoulos M1; Theocharis S1; Kavantzas N3; Perrea D4; Karandrea
D5; Mikhailidis DP6; Nicolaides AN7; Liapis C8
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AND IMMUNOHISTOCHEMICAL FEATURES
Introduction—Aim of Study:
Echolucent carotid plaques (type I and II) in patients with high-grade stenosis are associated with
cerebrovascular events. In an ongoing prospective study, we assessed the association between carotid plaque
echomorphology and vascular risk factors in symptomatic and asymptomatic patients. Histological and
immunohistochemical features of the plaques following carotid endarterectomy (CEA) were also evaluated.
Materials/Methods:
Patients (nZ149, median age 68 years, range 48–86, 118 men) with high-grade carotid stenosis [O70% for
symptomatic (nZ84) and O80% for asymptomatic patients (nZ65)] eligible for CEA were recruited so far. A
preoperative colour duplex ultrasound and brain CTscan was performed. A fasting blood sample was collected
preoperatively to measure established and emerging risk factors. The specimens were examined histologically
and immunohistochemically for metallothionein (MT) expression.
Results:
Echolucent plaques (more common in symptomatic patients, p!0.0001) were associated with a greater number
of pack-years of smoking (pZ0.001), increased circulating levels of high-sensitivity C-reactive protein (hs-CRP)
(p!0.0001), fibrinogen (pZ0.007), malondialdehyde (MDA) (pZ0.008) and homocysteine (Hcy) (pZ0.019).
Echolucent plaques had advanced lesions on histology (p!0.0001) and increased immunoreactivity for
macrophages (p!0.0001), fibroblasts (p!0.0001) and T-lymphocytes (pZ0.028) when compared with echogenic
plaques (types III and IV). The intensity of MT staining in macrophages and fibroblasts was increased in
echolucent plaques (both, pZ0.001).
Conclusions:
Echolucent plaques, with advanced lesions on histology, are associated with higher hs-CRP, fibrinogen (markers
of inflammation), Hcy (marker associated with vascular events and progression of carotid atherosclerosis) and
MDA (marker of oxidative stress) levels. These emerging risk factors may be useful for patient surveillance,
reflecting plaque vulnerability. They may also play a role in identifying high-risk asymptomatic patients who
will benefit from CEA. MT overexpression in echolucent plaques may represent a potential local protective
mechanism.19
Hayes PD, Payne D, Allrogen H, Hayes NJ, London NJL, Thompson MM, Bell PRF, Naylor
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POST-OPERATIVE ICA DIAMETER AFTER CAROTID ENDARTERECTOMY PREDICTS RESTENOSIS AND
IS RELATED TO GENDER AND PATCH TYPE
Introduction—Aim of Study:
Factors influencing restenosis after carotid endarterectomy (CEA) are incompletely understood. An improved
understanding of them may enable us to devise strategies for their prevention and so improve the long-term
outcome for CEA.
Materials/Methods:
In a prospective trial, 274 patients were randomised to saphenous vein or Dacron patch closure after routine
primary CEA. All patients were followed up regularly for 3 years (or until death) with clinical evaluation and
Duplex scanning of the CEA site. This data was studied to identify factors relating to the development of a
significant restenosis in the follow up period.EJVES Extra Vol 8, Month 2004
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Nineteen patients (6.9%) developed aO50% restenosis, none of whichwere associated with recurrent, ipsilateral
symptoms. Factors such as pre- or post-operative embolisation (markers of platelet activation), diabetes,
smoking and hypertension were not predictive of progression to restenosis (pZ0.64, 0.08, 1.0, 0.27 and 0.32,
respectively). Sixteen of the nineteen restenoses occurred within 12 months of surgery. Patients who ultimately
developed a O50% restenosis showed no sign of this when scanned at 30 days. However, these patients had
significantly smaller carotid bulb diameters when measured by Duplex ultrasound at this time (10.3 mm vs
11.5 mm, pZ0.025). Only two factors were associated with post-operative carotid diameter: gender and patch
type. Men had significantly larger carotid bulb diameters at six weeks than women (11.5 mm vs 10.8 mm, pZ
0.011). Vein patched patients also had greater bulb diameters at 30 days (12.1 mm vs 10.5 mm, !0.0001). The
relative risk of restenosis for women was 2.8 times greater than for men (95% CI 1.2–6.7, pZ0.023) and Dacron
patching was associated with a 5.4-fold increase in restenosis compared with vein (95% CI 1.6–18.0, pZ0.0018).
No woman randomised to vein closure developed a restenosis during the trial.
Conclusions:
Narrower post-operative carotid bulb diameter was associated with an increased risk of restenosis. Women have
smaller post-operative bulb diameters and higher rates of restenosis. The use of vein patch closure results in a
larger diameter bulb and may protect women from restenosis.20
Heckenkamp J, Lieder K, Lang E, Aleksic M, Gawenda M, Bendel MS, Brunkwall J
Division of Vascular Surgery, University of Cologne, Germany
RADIATION THERAPY INDUCED MODULATION OF WOUND HEALING AT EXPERIMENTAL VEIN
GRAFT ANASTOMOSES
Introduction—Aim of Study:
Vein graft (VG) restenosis due to anastomotic intimal hyperplasia is an unsolved problem. Radiation therapy
(RT) has been demonstrated to reduce restenosis after arterial interentions. However, the value of RT to also
prevent VG failure is unclear. Therefore the aim of this study was to investigate if RT favorably modulates
wound healing at VG anastomoses.
Materials/Methods:
Jugular VG were sewn into the carotid artery in 32 rats. Animals were randomly divided into 2 groups: RT
(gamma source, 14 Gray, nZ16) and control (C, sham irradiation, nZ16) animals. Longitudinal sections of VG
and adjacent arterial segments were analyzed at 2 (nZ8) and 8 weeks (nZ8) by histology, immunohistochem-
istry (anti-vimentin antibody), and morphometric analyses. Statistical analyses used the 2-tailed unpaired
Student’s t test.
Results:
Although RT did not reduce the overall occurrence of intimal hyperplasia, the distribution of intimal
hyperplasia differed. RT led to a reduction of intimal hyperplasia in the arterial segment (C: 0.024G0.010 mm2;
RT: 0.003G0.002 mm2, p!0.005). In contrast, RT led to a significantly increased intimal hyperplastic lesion in the
VG (C: 0.029G0.015 mm2; RT: 0.064G0.019 mm2, p!0.007). After RTcell numbers in intimal hyperplastic lesions
were lower after 2 weeks (C: 54G5; RT: 17G4, p!0.0001) but not at 8 weeks. VG diameters after RT were
enlarged at 8 weeks (C: 1.91G0.48 mm; RT: 3.25G0.56 mm, p!0.01). These findings did not affect patency rates.
80G12% of the cells present were of mesenchymal origin in both groups.
Conclusions:
RT reduced intimal hyperplasia in the arterial segment. However, RT led to aneurysmal degeneration and
increased intimal hyperplasia in the VG. There is a need to better understand the differences in arterial andEJVES Extra Vol 8, Month 2004
ESVS Abstracts—2004 63venous biology. RT is a promising approach to reduce restenosis after interventions in the arterial system.
However, with RT parameters commonly used, it did not favorably modulate vascular wound healing in VG.21
Bountouroglou DG, Azzam M, Kakkos SK, Pathmarajah M, Young P, Geroulakos G
Vascular Unit, Ealing Hospital, Department of Vascular Surgery, Imperial College of Science,
Technology and Medicine, London, UK
ULTRASOUND GUIDED FOAM SCLEROTHERAPY AND ADJUVANT HIGH TIE UNDER LOCAL
ANAESTHESIA
Introduction—Aim of Study:
This study is a prospective randomised comparison of procedure related complications, procedure cost
effectiveness, patient recuperation and quality of life outcomes between patients undergoing long saphenous
vein (LSV) stripping with high ligation, and patients undergoing ultrasound guided foam sclerotherapy and
LSV high tie under local anaesthesia.
Materials/Methods:
Sixty (28 males, 32 females, age 20–76, median 43) consecutive patients recruited from the varicose vein
outpatient clinic of Ealing Hospital, were randomly allocated to undergo ultrasound guided foam sclerotherapy
with adjuvant high ligation under local anaesthesia (group 1) versus high tie, stripping and multiple avulsions
under general anaesthesia (group 2). Inclusion criteria were: primary varicose veins involving the LSV system
and suitability for day case surgery. Thirty patients were randomised into each group. The study protocol
included history, physical examination, CEAP class and Venous Clinical Severity Score (VCSS) stratification,
colour duplex ultrasound, and completion of the Aberdeen Varicose Vein Questionnaire (AVVQ). Follow up
evaluation was performed at 3 weeks, 3 months and included history, physical examination, colour duplex
ultrasound. All patients with residual varicose veins received additional foam sclerotherapy (group 1), or liquid
injection sclerotherapy (group 2) as outpatients.
Results:
All patients in the two groups had immediate success on the day of treatment. There was a significant reduction
in operating time in favour of group one: 30–45 min (median 35), over group two 70–95 min (median 85) (p!
0.001, Mann–Whitney). The overall cost of the procedure in group one was significantly reduced over group two:
£164.88 versus £317.71. In the first follow up (3 weeks) there was no statistical difference in the complication rate
between the two groups. Six patients (20%) in group one needed a second session of ultrasound guided
sclerotherapy for full obliteration of the LSV system. In group two, two patients (6.67%) needed an additional
sclerotherapy session. Time to return to normal activities was significantly less in group one: 0–6 days (median
2), as compared to group two: 5–20 days (median 8) (p!0.001, Mann–Whitney). Forty-six patients (26 group one
patients and 20 group two patients) have so far been followed up at 3 months. Themedian CEAP class decreased
from 4 pre-operatively to 1 following treatment in both groups and the median VCSS score decreased from 5 to 1
in group one and from 7 to 3 in group two (p!0.001, Wilcoxon test). In group one three patients (10%) had
recanalised vein needing further sessions of foam sclerotherapy, resulting in a short-term closure rate of 90%.
Analysis of the AVVQ showed a statistically significant drop in both groups: from a median 15.4 to 9.3 in group
one and from 26.1 to 14.1 in group two after 3 months (p!0.001, Wilcoxon).
Conclusions:
There are significant early advantages in patients treated with ultrasound guided foam sclerotherapy and
adjuvant high ligation compared to traditional high ligation, stripping and multiple avulsions.EJVES Extra Vol 8, Month 2004
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CONSERVATIVE VERSUS SURGICAL TREATMENT OF VENOUS LEG ULCERS
Introduction—Aim of Study:
Subfascial Endoscopic Perforator Surgery (SEPS) combined with superficial vein ligation is performed with
good results in patients with advanced chronic venous insufficiency. This benefit, however, has never been
compared to conservative treatment. Therefore, we conducted a prospective, randomized, multicenter trial to
question if ambulatory compression therapy with venous surgery is a better treatment than just ambulatory
compression therapy in venous ulcer patients.
Materials/Methods:
Patients with an active venous leg ulcer (CEAP C6) qualified for the study. The study consisted of two treatment
groups. All patients were treated by standardized ambulatory compression therapy and half of the patients
underwent the SEPS-procedure. Concomitant superficial venous incompetence was treated in the second group.
The primary endpoint of the study was to compare the amount of time having an active ulcer during follow-up
in both study groups.
Results:
200 ulcerated legs (170 patients) were included in the study in twelve centers. 97 ulcers were allocated to the
surgical group and 103 to the conservative group. During a median follow-up of 27 months, an ulcer was active
in 28% of follow-up in the surgical group. In the conservative group this was 47% (pZ0.14 ANOVA). Patients
with recurrent ulceration or medially located ulcers in the surgical group have active ulceration for a significant
shorter period of time during follow-up than those treated in the conservative group (pZ0.02 both). Of three
strata, a first time ulcer and one of the centers had a positive effect on the primary endpoint (p!0.001 and pZ
0.02). The third, deep venous incompetence, did not affect the primary endpoint.
Conclusions:
Surgery positively affects outcome in patients with recurrent ulceration and/or medial ulcers. In this series 85%
of the patients complied with these criteria. Treatment should be offered in this patient population by a
dedicated center.23
Merchant RF, The Closure Group, The Reno Vein Clinic, USA
LONG TERM OUTCOME OF ENDOVASCULAR RADIOFREQUENCY OBLITERATION FOR TREATMENT
OF PRIMARY CHRONIC VENOUS INSUFFICIENCY—FIVE YEARS FOLLOW UP OF A MULTICENTER
PROSPECTIVE STUDY
Introduction—Aim of Study:
Radiofrequency obliteration has been accepted as an alternative to conventional vein stripping for treating
chronic venous insufficiency, and its short-term benefits over surgery have been demonstrated in three
randomized trials. An ongoing worldwide clinical registry was established in 1998 to prospectively follow-up
the treatment outcomes. This report reviews the long-term outcomes of the registry patients with preliminary 5-
year follow-up results.
Materials/Methods:
Patients with at least one annual follow-upwere analyzed. Clinical assessment and duplex ultrasound scanwere
performed before the procedure and at each follow-up. The CEAP clinical classification and the severity ofEJVES Extra Vol 8, Month 2004
Table 1. Treatment Outcome
Follow-up 1 year nZ458 2 years nZ240 3 years nZ119 4 years nZ107 5 years nZ37
Reflux free rates 90% 88% 87% 87% 84%
Varicose vein recur-
rence
14% 16% 14% 21% 22%
Fig. 1. Symptom improvement.
ESVS Abstracts—2004 65symptoms were documented. Reflux was defined as reverse flowO0.5 s in the target vein segment or in the area
of saphenofemoral or saphenopopliteal junctions.
Results:
A total of 539 limbs in 449 patients were included, 93.4% of limbs were C2-C4. Among veins treated, 96% were
great saphenous veins (GSV) with 86% limited to the thigh or just below the knee segments, 3% small saphenous
veins, and 1% accessory veins. The average vein diameter was 7.7 mm (2.2–19.4 mm). Adjunctive phlebectomy
and sclerotherapy was performed in 62 and 4% of the cases. Acute treatment success was achieved in 97% of
cases assessed by ultrasound scan within 1 week. The reflux-free and varicose vein recurrence rates at each year
are shown in Table 1. For the 37 limbs with 5-year follow-up, 31 (84%) of them exhibited no reflux and complete
GSV trunk occlusion. Symptomatic improvement remained persistent over 5 years as shown in Figure 1.
Conclusions:
This study demonstrates enduring treatment efficacy, persistent hemodynamic and clinical improvement
following the Closure procedure through 5-year follow-up.24
Wilson R, Molyneux K, Grierson CA, Bell PRF, Thompson MM
Department of Surgery, Leicester University, UK and Department of Vascular Surgery, St.
George’s Hospital Medical School, London
STATINS DECREASE PROTEOLYSIS IN THE WALL OF ABDOMINAL AORTIC ANEURYSMS (AAA)
Introduction—Aim of Study:
Abdominal aortic aneurysms (AAA) are characterised by aggressive remodelling of the extracellular matrix
proteins—elastin and collagen. An imbalance inMatrix Metalloproteinases (MMPs) and their inhibitors (TIMPs)
are responsible for the abnormal turnover of these proteins in AAA. 3-Hydroxy-3-methylglutaryl coenzyme-A
reductase inhibitors (statins) are known to reduce MMP levels in atherosclerotic lesions and in vitro biopsy
culture models of AAAwall. The aim of this study was to investigate the effect of statins on MMP levels in AAA
in vivo.EJVES Extra Vol 8, Month 2004
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Infrarenal aortic biopsies were obtained from the anterior sac of 53 consecutive patients undergoing
asymptomatic repair. Thirteen patients were taking statins (stAAA), while 40 were not (nstAAA). The
concentrations of total MMP-1, -2, -9, and TIMP-1 and -2 were quantified using ELISA. Based on the protein
results, real time PCR was conducted. Statistics used MWU.
Results:
There was no difference in the concentration of MMP-2 in stAAA and nstAAA (pZ0.869). The differences
between stAAA and nstAAA for MMP-1 (stAAAZ1.03 ng/mg [0.44–2.23] vs nstAAAZ1.78 ng/mg [1.05–3.24],
pZ0.099), and TIMP-2 (stAAAZ12.97 ng/mg [8.47–19.29] vs nstAAAZ7.4 ng/mg [4.07–16.53], pZ0.086)
approached significance. MMP-9 was significantly lower in stAAA (stAAAZ28.76 ng /mg [5.45–45.85] vs
nstAAAZ46.43 ng/mg [12.50–102.9], pZ0.028) and TIMP-1 was significantly elevated in stAAA (stAAAZ
244.2 ng/mg [141.3–299.5] vs nstAAAZ108.1 ng/mg [68.68–197.1], pZ0.012). Real time PCR however, revealed
no difference in MMP-9 or TIMP-1 mRNA levels between the groups.
Conclusions:
These data demonstrate that statins decreaseMMP-9 levels in AAA at the post-transcriptional level. Lowering of
MMP-9 levels with an increase in TIMP-1 concentrations may slow AAA progression and prevent rupture.
Unless there is a strong contraindication, all patients with AAA may benefit from a statin.25
Haulon S, Blanchemain N, Martel B, Traisnel M, Morcellet M, Hildebrand HF
Biomaterials Research Group UPRES EA 1049 and Vascular Surgery Unit, Faculte´ de
Me´decine de Lille, France
VASCULAR PET PROSTHESES SURFACE MODIFICATION WITH CYCLODEXTRIN COATING: DEVELOP-
MENT OF A NEW DRUG DELIVERY SYSTEM
Introduction—Aim of Study:
Cyclodextrins (CDs) are cyclic oligosaccharides, with a hydrophobic internal cavity and a hydrophilic external
wall. This configuration allows the CDs to capture molecules such as antibiotics and progressively release them
unmodified. We performed and analysed an antibiotic bounding of Polyester (polyethyleneterephtalate, PET)
vascular grafts, previously coated with cyclodextrins.
Materials/Methods:
The CDs coating process was based on the pad-dry-cure method patented in our laboratory. The PET prostheses
were immersed into a solution containing a polycarboxylic acid, a cyclodextrin (gamma or beta) and a catalyst,
placed into a thermofixation oven, and submitted to soxhlet extractions with water and ethanol before
impregnation with in an antibiotic solution (Vancomycinw). Antibiotic release in an aqueous medium was
assessed by UV spectroscopy. Surface modification was analysed by Scanning Electron Microscopy (SEM).
Wettability was determined with the drop contact angle method. The permeability of the prostheses was
assessed. Biocompatibility tests were performed with L132 human epithelial cells.
Results:
Cyclodextrins grafting was temperature and time dependent. SEM observation confirmed coating of PET fibres
by the cyclodextrin polymer. The permeability was respectively 300 and 50 ml/min/cm2 for uncoated and
coated prostheses. The water contact angle after 5 seconds was respectively 68 and 1198 for uncoated and coated
prostheses. Viability tests confirmed that the CDs polymer were not toxic towards L132 cell (92% survival rate
after 9 days). Cell proliferation, vitality, and adhesion was similar on coated and uncoated grafts. A linear release
of Vancomycinw was diagnosed during 40 days at a rate of 0.33 mg/l/day.EJVES Extra Vol 8, Month 2004
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Our results demonstrated the feasibility of cyclodextrin grafting on vascular prostheses. A decrease of 80% of the
permeability was obtained. Biological tests showed no toxicity of the different cyclodextrins used. A linear
release of Vancomycin was depicted over 40 days, demonstrating that cyclodextrins grafting was an efficient
drug delivery system.26
Pratesi Ga; Dorigo Wa; Pulli Ra; Alessi Innocenti Aa; Sofi Fb; Gensini Fb; Sticchi Eb; Lari Bb;
Fatini Cb; Abbate Rb; Pratesi Ca
aUnit of Vascular Surgery and Department of Clinical and Surgical Critical Care
bSection of Clinical Medicine, Thrombosis Centre, University of Florence, Florence, Italy
ACE DD GENOTYPE: A PREDISPOSITION FACTOR TO ABDOMINAL AORTIC ANEURYSM
Introduction—Aim of Study:
Genetic and environmental components contribute to the aetiology and progression of aortic aneurysms. To
date, ACE I/D and AT1R A1166C polymorphisms in genes encoding for Renin Angiotensin System (RAS)
components have been demonstrated to be associated with atherosclerotic lesions and ACE D allele has been
related to angiotensin II plasma levels. Experimental studies demonstrated that angiotensin II infusion
produced abdominal aortic aneurysm (AAA). In humans few data are available regarding the role of RAS in
aneurysm formation. This study was carried out in order to determine the role of these two polymorphisms in
the development of AAA.
Materials/Methods:
We investigated 250 consecutive patients, 217 males and 33 females (median age 72, range 50–83), undergone to
AAA elective repair and 250 healthy controls, comparable for sex and age. ACE and AT1R polymorphisms were
studied by PCR-RFLP analysis.
Results:
The genotype distribution was in Hardy-Weinberg equilibrium for all polymorphisms. The genotype
distribution and allele frequency of ACE I/D, but not AT1R A1166C polymorphism were significantly different
between patients and controls (ACE I/D: pZ0.0002 and p!0.0001, respectively and AT1R A1166C: pZ0.6 and
pZ0.4, respectively). An association between the ACE DD genotype and the predisposition to AAAwas found
(OR DD vs. IDCIIZ1.9 95% CI 1.3–2.9 p!0.0001). The OR for the predisposition to AAAvaried from 1.76 (pZ
0.019) in ID heterozygotes to 2.86 (p!0.0001) in DD homozygotes subjects, with a dose dependent effect. From
the multivariate analysis adjusted for age, sex, and traditional vascular risk factors, ACE DD genotype was
found to be independently related to the disease (OR DD vs. IDCIIZ2, 95% CI 1.2–3.3 pZ0.007).
Conclusions:
Our findings document a role for ACE gene I/D polymorphism in the pathogenesis of a complex disease, such
as AAA.27
Malmstedt J, Takolander R, Wahlberg E
Department of Vascular Surgery, Karolinska Hospital, Sweden
A RANDOMIZED PROSPECTIVE STUDY OF VALVULOTOME EFFICACY IN IN-SITU RECONSTRUCTIONSEJVES Extra Vol 8, Month 2004
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Total valve destruction is essential for achieving good results after in-situ bypass reconstructions. With
valvulotomes fixed in size it is considered more difficult to accomplish adequate valve destruction in the
proximal parts of the vein, while adjustable valvulotomes are more expensive. The purpose of this study was to
evaluate the efficacy of valve destruction with an adjustable (AV) and fixed valvulotome (FV).Materials/Methods:
Thirty consecutive patients scheduled for infrainguinal in-situ bypass with the greater saphenus vein were
randomized to use of either AV (LeMaitre) or FV (Mill) valvulotomes. The size of FVused, the number of times
the valvulotome was passed through the vein and the surgeon’s estimation of graft flow after valvulotomy were
registered. The number of valves cut and the effectiveness of valvular destruction were angioscopically
evaluated by a blinded examiner. The primary endpoint assessed was the number of insufficiently cut valves.Results:
Fifteen patients were randomized to each group but one from each was excluded due to angioscopy failure. The
valvulotomes tended to be passed through the vein more frequently in the FV group (mean 3.07 vs 2.54 number
of times, PZ0.09) and estimated graft flow was considered as good or adequate in all patients. Sixty-one valves
were evaluated in the AV and 62 in the FV group. The frequency of incompletely cut valves were similar (pZ
0.34) between the valvulotomes (AV 26%, nZ16, vs FV 27%, nZ17). More of the proximally located valve cusps
were incompletely cut in the AV group (57%, 8/14 vs 36% 5/14) but the difference was not statistically different
(pZ0.22). The only valvulotome related complication that occurred was minor and happened in the AV group.Conclusions:
Insufficiently destroyed valves are common but there is no difference in terms of efficacy between FV and AV.
The latter valvulotome also appears to overlook at least as many proximal valves as FV. Accordingly, this study
does not support the use of the more expensive adjustable valvulotomes.28
Smeets L1, Knight JS2, Morris GE2, Moll FL1
1Departments of Vascular Surgery, University Medical Centre Utrecht, The Netherlands and
2Southampton General Hospital, Southampton, UKMULTICENTRE STUDY TO ASSESS THE DEPLOYMENT CHARACTERISTICS AND DURABILITY OF A
NEW COVERED STENT AND DELIVERY SYSTEM IN THE TREATMENT OF FEMOROPOPLITEAL
OCCLUSIONSIntroduction—Aim of Study:
This study evaluates the clinical feasibility and efficacy of a new ePTFE covered stent and adjustable deployment
system (aSpire, Vascular Architects, USA) in combination with remote superficial femoral artery endarterectomy
(RSFAE) for the treatment of long segmental femoropopliteal occlusive disease. The stent is made from nickel
titanium (nitinol), manufactured in a double spiral configuration and covered with a thin sleeve of ePTFE.
Advantages of this stent are high radial force, flexibility and crush and kink resistance. The specific indication is
therefore arterial segments prone to flexion and extension -the external iliac, the distal SFA and proximal
popliteal. The delivery system ensures accurate placement, whilst the open spiral design maintains compliance,
promotes laminar flow and allows collaterals to be preserved.EJVES Extra Vol 8, Month 2004
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Five clinical sites in four European countries participated. Sixty-two limbs in 61 patients were treated with
RSFAE and aSpire stenting. Follow-up was by out patient clinical examination and duplex scanning at 1-, 6-, 12-
and 18- months.
Results:
The median follow-up was 17 months (range 2-34). The median age was 69 years (range 40-88 years), 41 patients
were male. Indications for intervention were disabling claudication in 56, and critical ischaemia in 6 procedures.
The mean diseased length of the SFAwas 25 cm. A mean of 1.3 stents (range 1-3) were deployed with a median
stent diameter of 7 mm (range 6-9). At 18-months the cumulative primary, primary-assisted and secondary
patency rates were 60%, 70% and 72% respectively. There were no device related adverse events, such as kinking
or fracturing and no stent migrations.
Conclusions:
Early results show that this spiral ePTFE covered stent can be used successfully after remote superficial femoral
artery endarterectomy. The results after two years are promising and long term follow up is required to
determine its final place in the endovascular armamentarium.29
Altaf N, Murphy R, Gladman J, Lowe J, Morgan PS, Delay GS, Jaspan T, Tennant WG, Auer D,
Moody AR and MacSweeney ST.
Queens Medical Centre, Nottingham, UK
THE DEGREE OF LEUKOARIAOSIS IS PREDICTED BY THE RUPTURED CAROTID ARTERY PLAQUE IN
SYMPTOMATIC PATIENTS
Introduction—Aim of Study:
Leukoariaosis (LA) or the presence of cerebral white matter changes in Magnetic Resonance (MR) brain scans is
a risk factor for stroke and vascular death. Previous studies have demonstrated no association between the grade
of carotid stenosis and the extent of LA. The aim of the study was to determine whether ipsilateral cerebral LA is
associated with histological complicated carotid plaque.
Materials/Methods:
57 consecutive symptomatic patients (withO69% carotid artery stenosis) underwent successful MR brain scans
and carotid endarterectomy (CEA). The number and volume of LA lesions seen in the MR brain scan of the
ipsilateral cerebral hemisphere were calculated using a computer image analysis program. All the
endarterectomy specimens underwent histological examination and graded according to the American Heart
Association (AHA) classification.
Results:
42/57 of the endarterectomy specimens were histologically defined as complicated (type V plaque) and 15/57
were non ruptured (type V plaque). There were more LA lesions in the patients with the type V plaque (mean
7.81versus 4.00, P!0.05). There was a greater volume of LA lesions in patients with the type V plaque, but this
was not significant (2170 mm versus 1589 mm, pZ0.53).The number and volume of LA lesions did not correlate
with the grade of ipsilateral carotid stenosis (Pearson Corr. 0.6 and 0.73 respectively, pO0.3).
Conclusions:
CEA patients who have a complicated histological carotid plaque have a greater number of LA lesions in their
affected cerebral hemisphere. It suggests that leukoariaosis is associated with the complicated carotid atheroma
and may be a result of embolism from that source.EJVES Extra Vol 8, Month 2004
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TREATMENT OF ARTERIOVENOUS MALFORMATION: CURRENT STATE OF PROBLEM
Introduction—Aim of Study:
Treatment of patients with arteriovenous malformations (AVM) remains a very difficult test of vascular surgery.
There has been an associated high reccurence rate. The purpose of this study was to review our experience with
combined treatment (embolization and surgical procedures) to manage AVMs.
Materials/Methods:
240 patients for AVM was investigated during 1985 through 2003 (34.3% of all CVM). Diffuse affection (two ore
more anatomical regions) was marked in 156 (65%). Microfistulae form was diagnosed in 35 (14.6%). In addition
to the conventional physical investigation and clinical-laboratory analyses duplex scanning (DS) of the arterial
andvenous vessels has been performed to all the patients. Computer-tomographic investigation was performed
in 64 patients. All patient underwent angiographic confirmation for planning of treatment.
Results:
Embolization with various combination (hydrogel embols, absolute ethanol, coils) was performed in 196
(81.7%). Periodic follow-up of the treatment results was made based on the DS, CT in the majority, especially
during multi-session therapy. 84 patients (35%) with surgically inaccessible lesions were treated only with
embolisation only. Mean sessions was 3.6. Radical resection of affected tissues (64) was perfomed after
embolisation, incomplete removal of angiomatosis with AVM—98. In some cases (microfistulae form)
sceletization of different arteries has included.
Conclusions:
Application of modern instrumental investigational methods allows to verify pathogenic mechanisms of
vascular malformations. Patients with AVM need constantly clinical examination to determine indication for
sessions embolization and surgical interventions.31
Bapat G, Butler PEM, Hamilton G, Cowen T, Burnstock G, Baker DM
University Department of Surgery, Royal Free and University College Medical School,
London, U.K.
UPREGULATION OF P2Y2 RECEPTORS ON HUMAN VASCULAR SMOOTH MUSCLE IN MICROVESSELS
AND AORTA IN RESPONSE TO ISCHAEMIA AND HYPOXIA
Introduction—Aim of Study:
Extracellular nucleotides are released in high concentrations from endothelial cells during hypoxia and shear
stress, aggregating platelets, inflammatory cells and from damaged smooth muscle cells. ATP and UTP have
been shown to be mitogenic for vascular smooth muscle cells an effect mediated by P2Y2 receptors. Our
objective was to examine the expression of P2Y2 receptors on smooth muscle cells of microvessels from human
calf skeletal muscle and from aorta and to investigate any changes in response to hypoxia and chronic ischaemia.
Materials/Methods:
Following local ethical committee approval, ten open calf muscle biopsies were obtained from each of two
groups of patients (nZ20): a non-ischaemia group undergoing coronary artery bypass surgery and a chronic
ischaemia group undergoing surgery for critical limb ischaemia. Human aortic smooth muscle cell culture linesEJVES Extra Vol 8, Month 2004
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humidified atmosphere of 5% CO2 in air. In the hypoxic group, cells were exposed to 1% O2/5% CO2/94% N2 in
a Billups-Rothenburge chamber for 18 hours. Each experiment was repeated three times (nZ3). Cells were
immunostained for P2Y2 receptors at semi confluent stage. The distribution and changes in immunostaining of
P2Y2 receptor was compared between the two groups following immunohistochemistry, using confocal
microscopy and quantitative image analysis.
Results:
Immunofluorescence staining identified P2Y2 receptors on vascular smooth muscle cells of microvessels in
skeletal muscle and in culture in both normal and hypoxic groups. Image analysis showed a significant up-
regulation of P2Y2 receptors in both ischaemic muscle microvessels (p!0.005) and smooth muscle cells grown
under hypoxic conditions (p!0.0001). (Statistical analysis: using two way ANOVA followed by a multiple
comparison post test Tukey test.)
Conclusions:
This study has shown P2Y2 expression on smooth muscle of human calf skeletal muscle microvessel and aortic
smooth muscle cells. We have shown for the first time that upregulation of P2Y2 receptors occurs in vivo and in
vitro in response to both chronic ischaemia and hypoxia. This upregulation may explain the reports of increase
in UTP- and ATP- stimulated proliferation of vascular smooth muscle cells demonstrated in atherosclerosis and
in neointimal formation after balloon angioplasty.32
van der Laan MJ1, Bartels LW1, Viergever MA2, Blankensteijn JD3
1Department of Surgery, Division of Vascular Surgery, University Medical Center, Utrecht;
2Image Sciences Institute, University Medical Center, Utrecht; 3Department of Vascular
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DYNAMICMRA FORTHE CHARACTERIZATIONOF ENDOLEAKS AFTER ENDOVASCULARANEURYSM
REPAIR
Introduction—Aim of Study:
To evaluate the added value of dynamic contrast enhanced magnetic resonance angiography (dynamic CE-
MRA) techniques over non-dynamic MRI and MRA for endoleak classification in the follow-up after
endovascular abdominal aortic aneurysm repair (EVAR).
Materials/Methods:
Twenty-eight patients, between 2 days and 54 months after EVAR, were evaluated with both standard MRI and
MRA-techniques and dynamic CE-MRA. All MRI scans were performed on a clinical 1.5-T scanner. Twenty-five
patients had an Ancure endograft and the other three had an Excluder endograft. The scans used for endoleak
classification from our MRI protocol were a pre-contrast T1-weighted scan, a T1-weighted scan acquired 5
minutes after Gd-DTPA contrast agent injection, and a dynamic CE-MRA. The diagnostic value of the dynamic
CE-MRAwas evaluated by determining the added value of the dynamic series in pinpointing the site of inflow
of an endoleak. Endoleak classification was performed by locating the site of inflow.
Results:
Using our standard protocol an endoleak was detected in 23 (65%) patients, entering our analysis. In sixteen
scans the dynamic series was technically successful. In our learning curve 4 scans were unsuccessful due to
inadequate scan planning and 2 were unsuccessful due to movement. The classification results for our standard
protocol were: 2 type I endoleaks, 6 Type II endoleaks, 1 type II endoleak, no type IV endoleaks and in 14 cases
classification could not be made. The classification results for our standard protocol plus the dynamic CE-MRA
were: 2 type I endoleaks, 12 Type II endoleaks, 1 type II endoleak, no type IV endoleaks and in 8 casesEJVES Extra Vol 8, Month 2004
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dynamic scans only. In six cases the dynamic MRA allowed exact classification of the endoleak, which was not
possible with the non-dynamic images alone.
Conclusions:
Dynamic CE-MRA has additional value in the classification of endoleaks and might obviate the need for
diagnostic digital subtraction angiography and aid planning for intervention33
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CAROTID ENDARTERECTOMYAFTER ISCHEMIC STROKE—IS THERE A JUSTIFICATION FOR DELAYED
SURGERY?
Introduction—Aim of Study:
A four to six week delay before performing carotid endarterectomy after ischemic stroke is still widely
recommended Data from recent studies suggest that endarterectomy is more effective or at least no more
harmful when carried out closer to the cerebrovascular event.
Materials/Methods:
We retrospectively analysed data from patients with carotid endarterectomy after ischemic stroke. We
investigated the time interval between the event and endarterectomy in relation to surgical results and
complications.
Results:
Between January 2000 and December 2003 107 patients underwent carotid endarterectomy after a recent stroke.
Endarterectomy was performed within six hours in 9 patients (8.1%); 28 (26.3%) were operated within four
weeks. The vast majority of the patients, 70 (65.6%) were treated at least four weeks after the cerebrovascular
event. Perioperative complications among patients treated within four weeks were 3.8% andwere comparable to
those treated after four weeks (4.2%). However 11% of the patients awaiting operation experienced a new
cerebrovascular event (ischemic stroke or carotid occlusion), most of them occurred in the third or fourth week
after the initial event.
Conclusions:
We conclude from our data, that carotid endarterectomy can be performed without increased risk within a
shorter delay after stroke. In addition severe cerebrovascular events occuring within the waiting periodmight be
avoided.EJVES Extra Vol 8, Month 2004
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EFFECTS OF TUNNELLING ON GEOMETRY, FLOW AND SHEAR IN INFRAGUINAL BYPASS GRAFTS
MEASURED BY THREE-DIMENSIONAL RESONANCE IMAGING RECONSTRUCTION
Introduction—Aim of Study:
The association between graft geometry, blood flow features (in particular shear stress), and myo-intimal
hyperplasia is well established. We have used novel three-dimensional reconstruction of MRI data of
infrainguinal bypass graft distal anastomoses to investigate geometrical configuration in vivo. We have
compared anastomoses between differing surgical techniques and anatomical location. This has allowed
analysis of haemodynamic variation using computational fluid dynamics.
Materials/Methods:
In vivoMRI data were acquired from 20 patients undergoing infrainguinal autologous vein bypass at a median 2
weeks postoperatively. Three dimensional surface-mesh reconstructions of the distal anastomosis were
produced and medial lines extracted allowing calculations of geometrical features, (planarity, graft-host
proximal angle and ratio of cross sectional area of host vessel and graft). Statistical analysis was performed using
the t test and Pearson’s correlation coefficient.
Results:
The graph shows the significant association between planarity and GPA (rZ0.5, pZ0.024). The table shows
geometry variation as mean and standard error of mean comparing surgical technique and location of distal
anastomosis (TPT denotes tibioperoneal trunk).
Planarity Graft proximal angle Ratio of cross sectional
area
Technique Tunnelled nZ12 4.5 (G1.2)* 27.9(G4.5) 0.51(G0.07)
Superficial nZ8 13 (G4.1) 46(G10.2) 0.42(G0.08)
Location TPT and proximal nZ9 8.1 (G3.4) 29.7(G7.8) 0.63(G0.07) **
Distal to TPT nZ11 7.7 (G2.4) 39.7(G7) 0.34(G0.04)EJVESConclusions:
This new MRI-based reconstruction technique demonstrates significant geometrical variation between human
vein grafts placed at different locations and using different tunnelling techniques. These findings may be
important in optimising graft longevity.Extra Vol 8, Month 2004
ESVS Abstracts—20047435
Guenther G, Zegelman M
Krankenhaus Nordwest Frankfurt, Germany
IN SITU RECONSTRUCTION OF VASCULAR GRAFT INFECTIONS WITH A SILVER IMPREGNATED
POLYESTER PROSTHESIS. A MULTICENTER 4 YEAR EXPERIENCE
Introduction—Aim of Study:
Vascular graft infections are a threatening problem. There are different treatment options. Over the last 4 1/2
years we collected data of patients in whom a vascular graft infection was treated by in-situ replacement with a
silver impregnated Dacron prosthesis.
Materials/Methods:
137 patient data from 60 different centres were included. In 90 cases the previously implanted graft material was
explanted completely followed by in-situ reconstruction with a silver impregnated Dacron graft. 47 patients
received an incomplete removal of the inlaying graft material.
Results:
In the group of partial graft explantation 20 patients had recurrent infections (42%). If the graft material was
explanted in its entirety there was a reinfection in 9 cases (10%). In cases of aortic graft infection the control of
infection succeeded in 92% in the group of complete graft removal, only in 62% if the graft material was removed
partially. In 11 patients we found a graft enteric fistula. 10 times a complete, once incomplete graft removal was
performed. All in-situ replacements were successful. Two Patients died unrelated to the reconstruction or any
reinfection 11 and 29 months after operation, which was proved by autopsy in 1 case and clinical appearance in
the other.
Conclusions:
The in-situ reconstruction with the silver impregnated Dacron graft should be combined with a complete graft
removal. To achieve success an additional concept with wound debridement, local antiseptic means and a
systemic antibiotic treatment should be followed. With these means we could achieve a clearing of the infected
situation in 90%; (92% in aortic position). All cases of graft enteric fistula could be cured. The strategy of in-situ
reconstruction with the silver impregnated Dacron graft is an effective treatment option. However, a new
European registry (www.eurigi.com) had been founded to compare and evaluate the current treatment of graft
infections in aortic position.36
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ROBOT-ASSISTED LAPAROSCOPIC AORTOBIFEMORAL BYPASS FOR AORTOILIAC OCCLUSIVE DIS-
EASE: EARLY CLINICAL EXPERIENCE
Introduction—Aim of Study:
Recently robot-assisted laparoscopic surgery (RALS) has become available for various procedures. Laparoscopic
vascular surgery requires advanced surgical skill. RALS has the advantages of motion scaling, instruments with
additional degrees of freedom, 3-D visualization and a stable camera field, thereby facilitating these complex
procedures. We present our clinical experience with two robotic surgical systems.
Materials/Methods:
Between February 2002 and April 2004, we performed robot-assisted laparoscopic aorto-bifemoral bypasses
(ePTFE) in eight men, median age 55 years (range: 36–64) for aortailiac occlusive disease. Dissection wasEJVES Extra Vol 8, Month 2004
ESVS Abstracts—2004 75performed laparoscopically and the robot was used to make the aortic anastomosis. The first five patients were
operated with a ZEUSw robot (Computer Motion, Inc., Santa Barbara, CA), while the latter three patients were
operated with a daVinciw Surgical System (Intuitive Surgical, Inc., Sunnyvale, CA).
Results:
Median operative time was 405 minutes (range: 260–589), with a median clamp-time of 111 minutes (range: 85–
205). Median blood loss was 900 ml (range: 200–5800). A robot-assisted anastomosis was successfully performed
in seven patients. Two patients were converted to a laparotomy, one due to bleeding of an earlier clipped lumbal
artery after completion of the anastomosis, the other due to difficulties with laparoscopic exposure of the aorta.
One patient died unexpectedly on post-operative day 3 as a result of a massive myocardial infarction. Median
hospital stay was 7.5 days (range: 3–57).
Conclusions:
Our initial experience with RALS shows it is a feasible technique for aortoiliac bypass surgery. With more
experience and technical improvements operative times need to be reduced before RALS can be widely
implemented for vascular procedures.37
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THE OUTCOME OF FAILED CONVENTIONAL INFRAGUINAL REVASCULARISATION IN THE DUTCH
BOA STUDY: COMPARISON OF VENOUS AND NON-VENOUS GRAFTS
Introduction—Aim of Study:
This study compares the consequence of occlusion of infrainguinal venous and prosthetic grafts regarding the
need for amputation.
Materials/Methods:
In total 2650 patients were included in the Dutch BOA study, a multicenter 2 randomised trial that compared the
effectiveness of oral anticoagulants with aspirin in the prevention of infrainguinal bypass graft occlusion and
other ischemic events. In this study 2404 patients who received a femoropopliteal or femorodistal bypass with a
venous (1546, 64%; 1140 femoropopliteal) or prosthetic (858, 36%; 793 femoropopliteal) graft were included. The
incidence of occlusion and amputation was calculated according to graft material and the incidence of
amputation after occlusion was compared using logistic regression to adjust for differences in prognostic factors.
Results:
The indication for operation was claudication in 51%, rest pain in 20% and tissue loss in 28% of patients. The
mean follow up was 21 months. After venous bypass grafting 171 (15%) femoropopliteal and 96 (24%)
femorodistal grafts occluded, leading to amputations in 28 (16%) and 27 (28%) patients, respectively. After
prosthetic bypass grafting 234 (30%) femoropopliteal and 25 (38%) femorodistal grafts occluded, followed by
amputation in 36 (15%) and 7 (28%) patients, respectively. Patients with occlusions in the venous group had
more severe ischemia, less runoff vessels and were older than the patients with prosthetic grafts. In the venous
group 55 (21%) amputations were performed compared to 43 (17%) in the PTFE group; crude odds ratio 1.30
(95% CI 0.84–2.03) After adjustment for above mentioned differences the odds ratio was 0.83 (95% CI 0.50–1.36).
Conclusion:
The need for amputation after occlusion is not influenced by graft material in infrainguinal bypass surgeryEJVES Extra Vol 8, Month 2004
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ENDOVASCULAR THORACIC ANEURYSM REPAIR IN FRANCE FROM 1999 TO 2001
Introduction—Aim of Study:
Since the introduction of endovascular aortic repair (EVAR) for thoracic aortic aneurysm (TAA), numerous small
clinical trials have been conducted throughout the world with variable results. The purpose of this study was to
assess overall short term results of EVAR for TAA in France.
Methods:
This retrospective study was designed by the French National Health Insurance Fund (CNAMTS) to allow
impartial analysis independent of administrative, commercial or local interests. Data was retrieved from patient
charts at each participating center and checked by medical advisors before being centralized for analysis.
Results:
Between June 1999 andMay 2001, a total of 166 EVAR procedures for TAAwere performed in 166 patients with a
mean age of 66 years (ASA 1–2: 23.9%, ASA 3: 55.8%, ASA 4: 18.6%, ASA 5: 1.6%). Most procedures were carried
out in public hospitals. Thirty EVAR (18.2%) were performed in compliance with the French Law for biomedical
research and only 40 patients (24%) signed informed consent statements. The diameter of the TAAwas less than
50 mm in 17.3% of cases, between 50 and 59 mm in 21.2%, and equal to or greater than 60 mm in 61.5%. Seventy-
six complications were noted on 61 charts (36.7%). There were 17 deaths (10.2%) including 8 occurringwithin the
first 30 days.
In the surviving patients EVAR-related complications included 3 ruptures, 3 aorto-esophageal or tracheal
fistulas, 27 endoleaks (16.3%) including 8 requiring further treatment, 6 paraplegia or paraparesia and 7 visceral
embolism. In addition there were 14 systemic complications (8.4%) and 14 vascular complications (8.4%) at the
iliac, femoral or brachial artery catheterization site. Multiple complications were observed in several cases. Sixty-
five of the 166 EVAR procedures (39.2%) were recorded in a national or international surveillance register.
Complete evaluation was done at 30 days, but only 69% of patients underwent complete postoperative
evaluation at 6-month using CT-scan with contrast media or angiography. Forty-one patients (31%) underwent
no postoperative imaging at 6-month.
Conclusion:
This national independent study demonstrates the need to improve the quality of clinical evaluation of new
medical devices in France. It also shows that EVAR for TAA is not a risk-free procedure.39
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RESULTS OF ENDOVASCULAR REPAIR OF INFLAMMATORYABDOMINAL AORTIC ANEURYSMS
Introduction—Aim of Study:
Endovascular repair has been advocated as the preferred treatment for inflammatory abdominal aortic
aneurysm (IAAA), while others have advised against its use, because of the risk of an increased inflammatory
response.
Materials/Methods:
Patients included in the EUROSTAR registry with IAAA (nZ52, 1.2%) were compared to those with aneurysms
without aortic fibrosis (nZ4236, 98.8%). Clinical, anatomic and procedural characteristics were subjected toEJVES Extra Vol 8, Month 2004
ESVS Abstracts—2004 77multivariate analysis to calculate the adjusted odds ratio (OR) and 95% confidence interval (CI) for each variable.
The mean follow-up period in patients with IAAAwas 23 months (range 1–60). Adverse events during follow-
up were compared for the study group and controls by life table analysis.
Results:
Eight patients (15%) with IAAA had preoperatively impairment of renal function and one had bilateral
hydronephrosis. Variables that were significantly associated with IAAA included younger age (p!0.0001, mean
difference 5.9, CI 3.8–8.0) and lower pulmonary risks score (OR 0.48, CI 0.24–0.97). At completion of the
endovascular procedure device/device limb stenosis was more frequently observed in patients with IAAA (OR
18.9, CI 3.62–99.2). Postoperatively a significant increase of the inflammatory reaction was observed at CT
examination in three patients and a decrease in five patients. In none of the patients the renal function
deteriorated significantly during follow-up. There were no differences with regard to the rates of adverse events
in patients with inflammatory AAA and controls.
Cumulative rates of outcome events at 3 years of follow-up% Freedom from Inflammatory aneurysm (nZ
52)Controls (nZ4236) p-valueDeath from all causes 92.8% 85.2% 0.67
Aneurysm-related death 98.1% 96.5% 0.95
Growth of the aneurysm 84.8% 86.8% 0.26
Post-EVAR rupture of AAA 100.0% 98.9% 0.99
Conversion to open repair 95.7% 95.9% .59
Secondary endovascular
intervention83.4% 90.4% 0.23Conclusions:
Operative and midterm results of endovascular repair were comparable in patients with IAAA and those with
aneurysms without inflammatory reaction.40
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ENDOVASCULAR TREATMENT OF AORTIC ARCH ANEURYSMS
Introduction—Aim of Study:
Endovascular treatment of the aortic arch is challenging because of its curvature and of the presence of the
brachio-cephalic vessels. The aim of this study is to review our clinical experience with endovascular treatment
of aortic arch aneurysms and to address the new problems in this area.
Materials/Methods:
From 1999 to 2004, 84 patients received endovascular treatment for diseases of the thoracic aorta at our
Institution. In 23 cases (21 males, 2 females, mean age of 70G9 years) the aortic arch was involved (proximal
neck in Criado’s zones “0”, “1”, and “2”). Different commercially available grafts were used (Gore, Talent,
Endomed, Cook).
Zone “2”: intentional over-stenting of the left subclavian artery was performed in 16 cases. The left subclavian
artery was previously revascularized only in the first 3 cases.
Zone “1”: over-stenting of the origin of the left common carotid artery was performed in 5 cases. An extra-
anatomical revascularization was performed as a simultaneous or staged procedure.
Zone “0”: over-stenting of the whole aortic arch was performed in 2 cases, with a simultaneous grafting of the
supra-aortic vessels from the ascending aorta.EJVES Extra Vol 8, Month 2004
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Perioperative mortality was 1/23 (4.3%); death was secondary to graft migration. Technical success was
achieved in 20/23 (86.9%) cases: we observed one small proximal endoleak that spontaneously resolved at 6
months follow-up, and one delayed surgical conversion for endograft rupture. No neurological deficit was
observed. At a mean follow-up of 16 (r. 1–41) months all 21 patients are alive and well, in absence of endoleak.
Conclusions:
Currently available sheaths and grafts are flexible enough to allow deploying in the arch in most instances. De-
branching of the aortic archwith surgical revascularization for zone “0” and “1” seems to be adequate to obtain a
satisfactory proximal landing zone.41
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GREAT VESSELS MANAGEMENT FOR ENDOVASCULAR EXCLUSION OF AORTIC ARCH ANEURYSMS
AND DISSECTIONS
Introduction—Aim of Study:
To present a new approach for the endovascular repair of Thoracic Aortic Aneurysms and Dissections (TAAD)
involving the aortic arch in high risk patients (HRP).
Materials/Methods:
Between May 1999 and April 2004, we treated 49 patients (mean age: 69G9) with industrial thoracic aortic
stentgrafts. Fourteen (28.6%) required transposition of great vessels before endovascular exclusion of the aortic
arch. We first performed a transposition of the supra-aortic vessels, including 7 total transpositions and 7
transposition of left great vessels (hemi-arch transpositions). Transpositions of the sole left SCA are not reported.
Total transpositions were achieved with bypass grafting from the ascending aorta (median sternotomy), while
hemi-arch transpositions were carried out with cervicotomy.
Results:
Amongst the 14 patients treated, we had a 100% procedural success althoughwe observed 2 transient early type-
1 endoleaks (14.3%). One patient died 2 days after the stentgrafting procedure frommulti-organ failure after iliac
rupture. During vessels transposition, we had 1 minor stroke. Related to stent graft deployment, we observed 2
major strokes, including the previous minor stroke (2/14Z14.3%). No paraplegia and no stent related
complication was reported. The in-hospital major stroke/death rate was 21.4%. Finally, 1 delayed Minor stroke
was related to left CCA bypass occlusion. During a mean follow-up of 13.6G5.8 months, 1 patient (7.1%) with
chronic oxygen-dependent respiratory failure died from pneumonia at 3 months. No late endoleak occurs. The
late exclusion rate of aneurysmal sac was 100%. No stent-related complication was seen, especially no aorto-
esophageal fistula.
Conclusions:
Transposition of supra-aortic vessels allows endovascular exclusion of the aortic arch in HRP with extended
TAAD. Aortic endografting after surgical transposition is a challenging technique that proved to be feasible and
offered good mid-term results. Specialized surgical centers with both endovascular and surgical expertise offer
the best management possibilities for these patients.EJVES Extra Vol 8, Month 2004
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ENDOVASCULAR TREATMENT OF ACUTE ABDOMINAL AORTIC ANEURYSMS
Introduction—Aim of Study:
Feasibility of endovascular aneurysm repair (EVAR) for acute abdominal aortic aneurysms (AAA) has been
demonstrated. Advantages of acute EVAR are avoidance of two critical steps used in open repair, i.e. laparatomy
and general anaesthesia. This study analyses the results of acute EVAR, in comparison to open repair, in a single
academic institution. In addition, it investigates the suitability of acute AAA for EVAR.
Materials/Methods:
All patients treated for an acute AAA from January 1998 to April 2004 were included. The mortality of open
endovascular treated patients was evaluated and compared. A differentiation was made between acute
ruptured and acute non-ruptured AAA, based on clinical findings at open repair, and on pre-operative CT scan
(i.e. retroperitoneal hematoma) in acute EVAR. Suitability was prospectively assessed in the year 2003 only, to
avoid learning curve bias and logistic bias as in earlier years.
Results:
A total of 244 patients were treated for an acute AAA. EVAR was performed in 37 patients. In-hospital mortality
was five patients (14%). Open repair was performed in 207 patients, with a mortality of 63 patients (30%)
Table 1. Mortality of acute abdominal aortic aneurysm (AAA) patients with open and endovascular treatment.
Open EVAR p*
N Mortality N Mortality
Acute ruptured 167 56 (34%) 22 5 (23%) 0.345
Acute non-ruptured 40 7 (18%) 15 0 0.171
Total 207 63 (30%) 37 5 (14%) 0.045
* Fisher Exact test.EJVES ExtIn 2003 a total of 41 patients were admitted for acute AAA. Two patients did not receive treatment due to age and
co-morbidity. Eight patients (21%) were not evaluated because an endovascular team was not immediately
present, in combination with hemodynamic instability. The remaining 31 patients (79%) were evaluated for
acute EVAR. Nine patients (29%) were suitable for acute EVAR. Twenty-two patients were considered unsuitable
because of following advert features: proximal neck length (nZ10), type D aorto-iliac configuration (nZ7),
unsuitable access (nZ1), a combination of previous (nZ3) and a mycotic AAA (nZ1).
Conclusions:
Acute EVAR shows promising initial results, but inclusion is still low.ra Vol 8, Month 2004
